β-Elemene Triggers ROS-dependent Apoptosis in Glioblastoma Cells Through Suppressing STAT3 Signaling Pathway
Shi-Zhong Cai1, Qian-Wei Xiong2, Li-Na Zhao3
1Department of Child and Adolescent Healthcare, Children's Hospital of Soochow University, Suzhou, China.
Abstract:
Glioblastoma is one of the most aggressive primary brain tumors with few treatment strategies. β-Elemene is a sesquiterpene known to have broad spectrum antitumor activity against various cancers. However, the signaling pathways involved in β-elemene induced apoptosis of glioblastoma cells remains poorly understood. In this study, we reported that β-elemene exhibited antiproliferative activity on U87 and SHG-44 cells, and induced cell death through induction of apoptosis. Incubation of these cells with β-elemene led to the activation of caspase-3 and generation of reactive oxygen species (ROS). Western blot assay showed that β-elemene suppressed phosphorylation of STAT3, and subsequently down-regulated the activation of p-JAK2 and p-Src. Moreover, pre-incubation of cells with ROS inhibitor N-acetyl-L-cysteine (NAC) significantly reversed β-elemene-mediated apoptosis effect and down-regulation of JAK2/Src-STAT3 signaling pathway. Overall, our findings implied that generation of ROS and suppression of STAT3 signaling pathway is critical for the apoptotic activity of β-elemene in glioblastoma cells.
Insights
Beta-elemene induces glioblastoma cell death by triggering apoptosis and reactive oxygen species (ROS) generation. This sesquiterpene suppresses the JAK2/Src-STAT3 pathway, offering a potential new glioblastoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Glioblastoma is an aggressive brain tumor with limited therapeutic options.
- Beta-elemene shows broad-spectrum antitumor activity, but its mechanism in glioblastoma is unclear.
- Understanding beta-elemene's effects on glioblastoma cell signaling is crucial for developing new treatments.
Purpose of the Study:
- To investigate the antiproliferative and pro-apoptotic effects of beta-elemene on glioblastoma cells.
- To elucidate the signaling pathways involved in beta-elemene-induced apoptosis.
- To determine the role of reactive oxygen species (ROS) and the JAK2/Src-STAT3 pathway in beta-elemene's mechanism of action.
Main Methods:
- Cell proliferation assays on U87 and SHG-44 glioblastoma cell lines.
- Assessment of apoptosis induction, caspase-3 activation, and ROS generation.
- Western blot analysis to evaluate the phosphorylation status of JAK2, Src, and STAT3.
- Inhibition studies using N-acetyl-L-cysteine (NAC) to assess the role of ROS.
Main Results:
- Beta-elemene demonstrated significant antiproliferative activity and induced apoptosis in glioblastoma cells.
- Treatment with beta-elemene led to increased caspase-3 activation and ROS generation.
- Beta-elemene suppressed the phosphorylation of JAK2, Src, and STAT3.
- Inhibition of ROS with NAC reversed beta-elemene-induced apoptosis and JAK2/Src-STAT3 pathway suppression.
Conclusions:
- Beta-elemene induces apoptosis in glioblastoma cells through ROS generation and suppression of the JAK2/Src-STAT3 signaling pathway.
- ROS generation is a critical mediator of beta-elemene's apoptotic effects.
- Targeting the JAK2/Src-STAT3 pathway and ROS production represents a promising therapeutic strategy for glioblastoma.
